Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

Christian Rolfo; Andrés F. Cardona; Massimo Cristofanilli; Luis Paz-Ares; Juan Jose Diaz Mochon; Ignacio Duran; Luis E. Raez; Alessandro Russo; Jose A. Lorente; Umberto Malapelle; Ignacio Gil-Bazo; Eloisa Jantus-Lewintre; Patrick Pauwels; Tony Mok; María José Serrano

doi:10.1016/j.critrevonc.2020.103058

Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

Christian Rolfo^*, Andrés F. Cardona, Massimo Cristofanilli, Luis Paz-Ares, Juan Jose Diaz Mochon, Ignacio Duran, Luis E. Raez, Alessandro Russo, Jose A. Lorente, Umberto Malapelle, Ignacio Gil-Bazo, Eloisa Jantus-Lewintre, Patrick Pauwels, Tony Mok, María José Serrano

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Politècnica de València; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.

Original language	English (US)
Article number	103058
Journal	Critical Reviews in Oncology/Hematology
Volume	154
DOIs	https://doi.org/10.1016/j.critrevonc.2020.103058
State	Published - Oct 2020

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.critrevonc.2020.103058

Fingerprint

Dive into the research topics of 'Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))'. Together they form a unique fingerprint.

Cite this

Rolfo, C., Cardona, A. F., Cristofanilli, M., Paz-Ares, L., Diaz Mochon, J. J., Duran, I., Raez, L. E., Russo, A., Lorente, J. A., Malapelle, U., Gil-Bazo, I., Jantus-Lewintre, E., Pauwels, P., Mok, T., & Serrano, M. J. (2020). Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978)). Critical Reviews in Oncology/Hematology, 154, Article 103058. https://doi.org/10.1016/j.critrevonc.2020.103058

Rolfo, Christian ; Cardona, Andrés F. ; Cristofanilli, Massimo et al. / Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice : Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978)). In: Critical Reviews in Oncology/Hematology. 2020 ; Vol. 154.

@article{529f879ebfdc49dc8813cc0d6ef00917,

title = "Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))",

abstract = "The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Polit{\`e}cnica de Val{\`e}ncia; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.",

author = "Christian Rolfo and Cardona, {Andr{\'e}s F.} and Massimo Cristofanilli and Luis Paz-Ares and {Diaz Mochon}, {Juan Jose} and Ignacio Duran and Raez, {Luis E.} and Alessandro Russo and Lorente, {Jose A.} and Umberto Malapelle and Ignacio Gil-Bazo and Eloisa Jantus-Lewintre and Patrick Pauwels and Tony Mok and Serrano, {Mar{\'i}a Jos{\'e}}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",

year = "2020",

month = oct,

doi = "10.1016/j.critrevonc.2020.103058",

language = "English (US)",

volume = "154",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

Rolfo, C, Cardona, AF, Cristofanilli, M, Paz-Ares, L, Diaz Mochon, JJ, Duran, I, Raez, LE, Russo, A, Lorente, JA, Malapelle, U, Gil-Bazo, I, Jantus-Lewintre, E, Pauwels, P, Mok, T & Serrano, MJ 2020, 'Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))', Critical Reviews in Oncology/Hematology, vol. 154, 103058. https://doi.org/10.1016/j.critrevonc.2020.103058

Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978)). / Rolfo, Christian; Cardona, Andrés F.; Cristofanilli, Massimo et al.
In: Critical Reviews in Oncology/Hematology, Vol. 154, 103058, 10.2020.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice

T2 - Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

AU - Rolfo, Christian

AU - Cardona, Andrés F.

AU - Cristofanilli, Massimo

AU - Paz-Ares, Luis

AU - Diaz Mochon, Juan Jose

AU - Duran, Ignacio

AU - Raez, Luis E.

AU - Russo, Alessandro

AU - Lorente, Jose A.

AU - Malapelle, Umberto

AU - Gil-Bazo, Ignacio

AU - Jantus-Lewintre, Eloisa

AU - Pauwels, Patrick

AU - Mok, Tony

AU - Serrano, María José

PY - 2020/10

Y1 - 2020/10

N2 - The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Politècnica de València; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.

AB - The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Politècnica de València; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.

UR - http://www.scopus.com/inward/record.url?scp=85089514258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089514258&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2020.103058

DO - 10.1016/j.critrevonc.2020.103058

M3 - Comment/debate

C2 - 32823147

AN - SCOPUS:85089514258

SN - 1040-8428

VL - 154

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

M1 - 103058

ER -

Rolfo C, Cardona AF, Cristofanilli M, Paz-Ares L, Diaz Mochon JJ, Duran I et al. Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978)). Critical Reviews in Oncology/Hematology. 2020 Oct;154:103058. doi: 10.1016/j.critrevonc.2020.103058

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this